Leucine Announces USD 7 Million Series A Funding Round
This funding round also saw participation from all existing investors, including Pravega Ventures, Axilor Ventures, Techstars, and angels.
Global Pharma | 27/10/2023 | By Manvi | 589
Ceremorphic Announces Formation of New Life Sciences Division
Ceremorphic announced the formation of a new life sciences division called “Ceremorphic Life Sciences,” which has been established to transform the entire drug discovery and development process.
Global Pharma | 27/10/2023 | By Manvi | 577
CPHI Annual Report Predicts Contract Services Growth in 2024
New research from the CPHI Annual Report 2023 – launched during CPHI Barcelona, the world’s largest pharma event.
Global Pharma | 27/10/2023 | By Manvi | 384
CPHI Barcelona Announces Winners of Prestigious 2023 CPHI Pharma Awards
The awards recognise outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories.
Global Pharma | 27/10/2023 | By Manvi | 708
Refeyn Expands the Analytical Possibilities for High Concentration Samples by MassFluidix HC
Refeyn® has unveiled its latest innovation, the MassFluidix® High Concentration (HC) microfluidic system, which extends the analytical strength of mass photometry to high-concentration protein samples.
Global Pharma | 26/10/2023 | By Manvi | 638
CPHI Barcelona 2023: Sustainability Commitments Accelerating in Pharma Supply Chain
Sustainability goals and metrics are now being implemented across the pharma supply chain, with the rate of adoption accelerating quickly.
Global Pharma | 26/10/2023 | By Manvi | 334
Rossari Biotech's Subsidiary to Expand Ethoxylation Capacity
The project will be funded through a mix of internal accruals and debt.
Global Pharma | 26/10/2023 | By Manvi | 689
As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China and globally.
Global Pharma | 26/10/2023 | By Manvi | 748
Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023
Juniper Biologics has been honored with the prestigious title of the 'Most Innovative Oncology Pharmaceutical Company 2023' by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.
Global Pharma | 26/10/2023 | By Manvi | 345
Clariant Launches New Range of Excipients to Improve Stability and Solubility of APIs
Clariant will announce new additions to its portfolio of high-performing pharmaceutical ingredient solutions to support the evolution of safe and effective medicines.
Global Pharma | 23/10/2023 | By Manvi | 470
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy